DTB select: Warning on use of ondansetron in first trimester of pregnancy

Summary and context provided on warning from European Medicines Agency (EMA) about small increased risk of orofacial cleft malformations when ondansetron is taken during first trimester of pregnancy. It is noted that UKTIS and ENTIS do not support the SPC changes made by the EMA.


Drug and Therapeutics Bulletin